Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the TEAM pathology study.

The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

A female infant presented with a month-long history of dry cough, along with two episodes of fever and increased work of ...

Despite progress in clinician awareness and therefore identification and the development of treatment algorithms by oncologists for irAEs over the last decade ... both the anti-cancer therapeutic ...

The second phase of the Global Sources Hong Kong Shows opened today at AsiaWorld-Expo, running from October 18 to 21. The four-day event combines four major trade shows: the Mobile Electronics, Smart ...